Dr. Clausell earned his doctoral degree in Clinical-Community Psychology from the University of Illinois at Urbana-Champaign in 2011. Dr. Clausell’s graduate research focused on the legacy of childhood attachment relationships on relationship satisfaction of Gay and Lesbian Romantic Couples. Results of this research were published in the journal Developmental Psychology (2008). He completed his Predoctoral Clinical Internship at Veterans Affairs Palo Alto Health Care System and served as a Postdoctoral Research Fellow in Clinical Psychology in the Department of Psychiatry and Behavioral Sciences, Stanford Medicine. Dr. Clausell currently serves as the Director of the Couples & Family Program at Veterans Affairs Puget Sound Health Care System, Seattle Division. In addition, Dr. Clausell serves as Lead Trainer and Consultant in VA Central Office of Family Services for the dissemination program of Integrative Behavioral Couple Therapy lead by Developer & Distinguished Research Professor Dr. Andrew Christensen, at University of California, Los Angeles. Currently, Dr. Clausell serves as clinical trainer and supervisor for Seattle VA’s Clinical training programs, including Predoctoral, Postdoctoral, and the University of Washington Department of Psychiatry and Behavioral Sciences Resident Program where he currently serves at Rotation Supervisor for the VA Outpatient Couple and Family Therapy Rotation.
As a clinical and quantitative psychologist, my work bridges statistical practice and psychological theory to better identify for whom, under what conditions, and why substance-related health disparities are greatest across development. My substantive research seeks to understand how individual differences in stress and developing self-regulation shape substance use and disorder from adolescence through young adulthood, and how these associations explain substance use disparities among sexual and gender minoritized communities. Stemming from this work, my methodological research is centered on improving the analysis and interpretation of nonlinear effects spanning parametric and non-parametric methodologies.
Christina Warner, MD (she/her) is the attending psychiatrist for the Early Psychosis Clinic and Partial Hospitalization Program at Seattle Children’s Hospital. She has clinical expertise in mood disorders, psychosis spectrum disorders, First Episode Psychosis, chronic suicidality, mood dysregulation, neurodiversity, and Dialectical Behavior Therapy.
Dr. Warner is a Washington native and graduate of the Seattle Public School system with a vested interest in expanding access to high quality mental health care in her community.
I am a faculty member and licensed clinical psychologist in the University of Washington’s Department of Psychiatry and Behavioral Sciences. Before joining this department, I completed my Ph.D. in clinical psychology at Purdue University, residency at the University of Washington, and fellowship at the University of Pennsylvania.
My research interests primarily center around romantic relationship functioning and personality disorder (PD) measurement. My line of PD research centers around how the use of a trait-based, dimensional approach to assessing and measuring PDs may increase construct validity, reliability, and diagnostic accuracy relating to PDs. My romantic relationship research centers around how romantic relationship functioning and interpersonal behaviors are associated with psychopathology diagnoses and symptoms.
As a clinician, I specialize in treating suicidality and self-harm using comprehensive Dialectical Behavior Therapy; in treating PTSD using Cognitive Processing Therapy and Prolonged Exposure; and in treating anxiety-related disorders using exposure therapies like Exposure and Response Prevention for OCD and Exposure for Social Anxiety. I am also passionate about providing couples’ therapy.
Dr. Connor Gallik, PhD, is the attending psychologist for the Adolescent Program on the Psychiatry and Behavioral Medicine Unit at Seattle Children’s Hospital and Acting Assistant Professor in the Department of Psychiatry and Behavioral Sciences at University of Washington.
Prior to joining the staff and faculty at Seattle Children’s/UW, Dr. Gallik completed his graduate education at the University of Connecticut with an emphasis in child and adolescent clinical psychology. He completed his clinical internship at Pacific University’s Psychology and Comprehensive Health Clinic and went on to complete a postdoctoral fellowship in clinical psychology at Seattle Children’s Hospital with an emphasis in DBT and inpatient care.
His research focuses on understanding factors related to the mental health and wellbeing of transgender and gender diverse (TGD) TGD youth and evidence-based practice on inpatient units. Clinically, he is interested in working with children, adolescents, and their families, with a focus on TGD youth. Dr. Gallik also provides training in TGD affirming care for mental health and medical professionals and speaks to community audiences about supporting transgender youth.
Dr. Blayney’s research aims to understand the risks for and consequences of sexual victimization. More specifically, this work centers around how social contexts influence sexual victimization risk as well as variation in post-victimization recovery, such as posttraumatic stress disorder, alcohol use, and sexual risk behaviors.
I am a perinatal and addiction psychiatrist and Assistant Professor in the Department of Psychiatry and Behavioral Sciences. My main area of interest and expertise is substance use disorders in the perinatal period as well as perinatal and reproductive psychiatry more generally. I am also passionate about doing my part to address inequities in healthcare.
I am a child and adolescent psychiatrist at Seattle Children’s Hospital and faculty member at the University of Washington Medicine. My SCH practice locations include the Gender Clinic (Adolescent Medicine), Outpatient Psychiatry Clinic, Autism Center, and the inpatient unit- Psychiatry and Behavioral Medicine Unit (PBMU). I believe in delivering compassionate, evidence-based care in supporting patients and their families. My approach is both comprehensive and patient-centered, as it is important to consider the needs of the individual while also appreciating societal and cultural context. I specialize in working with diverse patient populations with various marginalized identities, such as those who identify as LGBTQ, gender diverse, and/or neurodiverse. I also work closely with the Adolescent Medicine Gender Clinic in supporting any mental health needs of transgender/gender diverse youth and their families. I also collaborate with colleagues in specialty medical clinics to coordinate care of medically complex patients. Additionally, I serve as a consultant with various school programs to support mental health initiatives and advocacy efforts.
Academically, I am involved with several initiatives both locally and nationally, particularly those that work to promote diversity and equity. I serve on committees supporting the SCH/UW CAP Fellowship Program, educating trainees and students through direct clinical supervision as well as with lectures and discussions. On a national level, I serve on the Sexual Orientation and Gender Identity Issues Committee (SOGIIC) for the American Academy of Child and Adolescent Psychiatry (AACAP). My clinical research focuses on finding strategies to better support the mental health and well-being of patients and families who are LGBTQ+. Additionally, I work on studies that explore the intersection between gender diversity and neuro diversity/autism spectrum.
Personal Statement
Over the last 25 years, my work has focused on relationships between stress and health in several risk groups (spouse caregivers of persons with Alzheimer’s disease, medical students, psychiatric/medical outpatients/inpatients, air traffic controllers, and camp counselors). We have developed and/or revised measures of medical student stress, caregiver burden, patient anger/dyscontrol, process coping, appraisal, neuropsychological function and physician awareness of patient problems. These measures have been used by university researchers, insurance companies, pharmaceutical companies in clinical trials, prisons, nursing homes/long term care, rehabilitation facilities, and public health organizations. These psychosocial and behavioral measures have been shown to predict and be predicted by physiological and cognitive measures. We have also focused on moderators of such relationships, such as gender, personality, and co-morbidities. We have used primarily multicohort long-term studies that allow for interactions between exposures to stressors, hard-wired vulnerabilities, and more temporal resources. We attempted to identify mechanisms that can be potentially altered to have long-term public health significance in persons under chronic stress. I have also attempted to isolate groups that are at high risk for negative outcomes. In a perfect world, interventions should be used to help all persons who have deleterious responses to stress, but society cannot afford this. For this reason, the identification of high risk groups is imperative for maximizing the effect of interventions.
My research program’s long range goal is to better understand the mechanisms by which chronic stress translates into physical, mental, or cognitive health problems. We are examining caregivers of spouses with AD and demographically-similar spouse non-caregivers across time and assessing the degree to which elevated depression, stress hormones, inflammation, and insulin resistance in caregivers predict cognitive decline in caregivers relative to non-caregivers. We are also attempting to replicate our earlier work that showed that chronic stress and chronic disease moderate each other’s physiological risks. For example, physiological dysregulation that is specific to a disease (e.g., metabolic syndrome with CHD, blood pressure reactivity with hypertension, and immune function with cancer history, HbA1c with diabetes) is exacerbated in caregivers with a chronic disease relative to non-caregivers with a chronic disease, but no such differences occur in caregivers versus non-caregivers without a chronic disease. Finally, we are examining a large cohort of older adults sampled from various U.S. communities in order to assess the influence of life stressors on long term cognitive function and potential mediators of such changes.
